leisure time -WSS

leisure time

author：leisure time 2025-08-12 08:29:52 - browse：835

Paul Biondi Flagship

Pharma giant Pfizer is turning to venture firm Flagship for new drug development, signing a deal worth up to $7 billion to mine new medicines from the latter’s portfolio companies.

Flagship and Pfizer announced Tuesday that they will each put $50 million into developing up to 10 drug candidates. Pfizer will have first rights to acquire each for up to $700 million, plus royalties. Flagship’s portfolio companies will also share in any payments that come out of the partnership.

Flagship has historically developed new medicines by forming and spinning out startup companies, some of which have signed their own collaboration deals with the likes of Amgen or Nestlé Health Science. But in recent years, the firm has been pursuing external partnerships through a new business division called Pioneering Medicines, led by former Bristol Myers Squibb executive Paul Biondi. Pioneering Medicines uses technologies and other scientific platforms being developed by Flagship’s portfolio companies to look for possible therapies in disease areas that the startup may not be working in.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： The most pressing bird flu mysteries scientists want answered

WSS

Naloxone nonprofit donates 200,000 doses after FDA approval

Sutter Health’s antitrust win overturned by appeals court

Anthony Fauci pushes back on GOP claims during Covid hearing

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

FTC loses bid to block Novant's North Carolina hospital merger

Medicare Advantage's lean provider networks lead CMS complaints

entertainment

leisure time

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Stopping antidepressants leads to symptoms for 1 in 6 patients

Supreme Court strikes down use of affirmative action

STAT wants to know your pick for a great summer read or listen

BioMarin wins approval for gene therapy to treat hemophilia A

Anthony Fauci pushes back on GOP claims during Covid hearing

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

In Memoriam: Notable people who died in 2023

Wegovy trial has doctors encouraged over new possibilities

leisure time

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

Twitch streamer Kai Cenat speaks out for 1st time since causing mayhem with Union Square giveaway

Drastic changes should bring profitability, startup health insurers say

A biotech analyst on neuroscience, placebo effect, not over

Hawaii wildfires fueled by Hurricane Dora's winds prompt evacuations

FTC loses bid to block Novant's North Carolina hospital merger

Wikipedia

hotspot

leisure time

knowledge